On Friday, August 28, the Mayor of San Diego, Kevin Faulconer, visited SBP to learn more about how our Institute is conducting world-class research dedicated to finding cures for human disease.
The Mayor was first welcomed by Perry Nisen, MD, PhD, CEO of SBP and Kristiina Vuori, MD, PhD, President of the Institute. Drs. Nisen and Vuori shared how SBP is evolving as a hybrid organization that blends cutting-edge fundamental research and robust drug discovery with a clear line of sight to the patient in a way that cannot be accomplished in academia, pharma, or biotech. Our goal is to combine our world-class research with clinical science to translate discoveries into important new diagnostic and therapeutic medical advances.
Mayor Faulconer continued his visit with a tour of the Conrad Prebys Center for Chemical Genomics, led by Michael Jackson, PhD, senior vice president, Drug Discovery and Development. Since its opening, the Center has been shortening the distance between basic research findings and therapeutic discoveries. Dr. Jackson presented how the Center uses high-throughput robotic technology to systematically screen up to one million chemicals per day to find the few that are potential starting points for new medicines.
It was an honor to welcome the mayor and share our commitment to finding new ways of restoring health and hope to patients everywhere.
